


A stiff neck after a long workday, a sudden back spasm, or a sprained muscle can stop a person from moving normally. Doctors often prescribe a medicine that fights pain and muscle tightness together, so patients recover faster. Etoricoxib 60 mg + Thiocolchicoside 4 mg I.P tablets serve this purpose. This guide explains how the combination works, where doctors use it, and which safety rules matter. It also shows why this product attracts distributors who want to join a PCD pharma franchise company in India.
This is a fixed-dose combination with two active ingredients:
“I.P.” means the tablets meet the standards of the Indian Pharmacopoeia. Doctors and chemists value this quality mark.
Painful muscle conditions usually involve two problems at once: inflamed tissue and a tight, contracted muscle. One drug rarely solves both.
Etoricoxib blocks the COX-2 enzyme, which drives the chemicals behind pain and swelling. Because it targets COX-2 more than COX-1, it often causes less stomach irritation than older, non-selective NSAIDs.
Thiocolchicoside acts on the nervous system and reduces involuntary muscle contraction. Stiff muscles loosen, and movement improves.
Together, the two drugs relieve pain, ease spasm, and restore mobility.
Doctors prescribe this combination for acute painful muscle conditions, including:
The combination treats short-term problems. It does not cure chronic disease.
| Benefit | What It Means for the Patient |
| Dual action | Treats pain and spasm in one tablet |
| COX-2 selectivity | Offers a gentler stomach profile than many older NSAIDs |
| Faster mobility | Patients return to normal movement sooner |
| Fewer tablets | One tablet replaces two separate drugs |
| Familiar molecules | Orthopaedic doctors and physicians know both drugs well |
A doctor decides the right dose for each patient. In general:
Patients must never extend the course without medical advice. Regulators have set clear short-term limits for Thiocolchicoside because of safety concerns, and Etoricoxib also works best at the lowest effective dose for the shortest time.
Honest safety messaging builds trust with doctors and patients.
This medicine needs a prescription. Self-medication carries real risk.
Etojon-TH4 | Ojana Pharmaceutical offers this combination to franchise partners. It enters pain management and orthopaedics, a therapy area with steady demand.
Why does this product suit distributors?
The Indian pharmaceutical industry keeps expanding, which creates room for new franchise partners. Industry sources report these trends:
Note: Market figures change every year. Verify the latest numbers on IBEF, the Department of Pharmaceuticals, or IQVIA before you publish.
A PCD pharma franchise company in India allows you to market branded medicines in your own territory. PCD means Propaganda Cum Distribution. You promote the company’s products, handle local sales, and build your own business identity.
This model suits medical representatives, chemists, distributors, and first-time entrepreneurs.
Buyers often search for the top 10 PCD pharma franchise companies in India before they commit. No official ranking exists, so judge each company on facts. Use this checklist:
A company that meets most of these points deserves a place on your shortlist.
In 2026, doctors continue to prescribe Etoricoxib 60 mg + Thiocolchicoside 4 mg I.P tablets for acute low back pain, neck pain, muscle spasm, and sprains. They relieve pain and muscle tightness together.
Current 2026 guidance keeps Etoricoxib 60 mg + Thiocolchicoside 4 mg I.P tablets to short courses, usually up to 7 days. Patients should follow their doctor’s advice and never extend the course alone.
Yes. In 2026, Etoricoxib 60 mg + Thiocolchicoside 4 mg I.P tablets remain prescription medicines in India. Chemists should dispense them only against a valid prescription.
Users in 2026 may notice nausea, indigestion, dizziness, drowsiness, or ankle swelling with Etoricoxib 60 mg + Thiocolchicoside 4 mg I.P tablets. Patients should contact a doctor if symptoms continue or worsen.
Safety guidance in 2026 advises pregnant and breastfeeding women, patients with heart disease or stroke, uncontrolled high blood pressure, seizures, or stomach ulcers to avoid Etoricoxib 60 mg + Thiocolchicoside 4 mg I.P tablets.
Etojon-TH4 | Ojana Pharmaceutical is a branded tablet that contains Etoricoxib 60 mg + Thiocolchicoside 4 mg I.P tablets. The company offers it to franchise partners who want a pain-management product in their range.
Demand for pain relief stays strong in 2026 as the Indian pharma market moves toward its USD 130 billion target for 2030. Etoricoxib 60 mg + Thiocolchicoside 4 mg I.P tablets give a PCD pharma franchise company in India a reliable, repeat-prescription product.
Check licences, GMP certification, territory rights, and batch quality reports. In 2026, choose a company that supplies Etoricoxib 60 mg + Thiocolchicoside 4 mg I.P tablets with transparent terms and reliable delivery.
Etoricoxib 60 mg + Thiocolchicoside 4 mg I.P tablets deliver dual relief for painful muscle conditions, and doctors trust them for short-term care. For entrepreneurs, Etojon-TH4 | Ojana Pharmaceutical offers a strong entry into the pain-management segment. Choose your franchise partner with care, verify every claim, and promote the product with honest, safe-use messaging.
Disclaimer: This article provides general information only. It does not replace professional medical advice. Always consult a qualified doctor before you use any medicine.